Mycobacterium Citations List: August 2024

Literature Citations

1. Crystal Structure of Dihydroneopterin Aldolase from Mycobacterium Tuberculosis Associated with 8-mercaptoguanine, and Development of Novel S8-functionalized Analogues as Inhibitors: Synthesis, Enzyme Inhibition, In Vitro Toxicity and Antitubercular Activity. Czeczot, A.M., M.N. Muniz, M.A. Perelló, E.D. Silva É, L. Timmers, A. Berger, L.C. Gonzalez, G. Arraché Gonçalves, S. Moura, P. Machado, C.V. Bizarro, and L.A. Basso. Journal of Enzyme Inhibition and Medicinal Chemistry, 2024. 39(1): 2388207. PMID[39140692]. PMCID[PMC11328599].
[PubMed]. TB_08_2024.

2. In Vitro Identification of Underutilized Β-lactam Combinations against Methicillin-resistant Staphylococcus aureus Bacteremia Isolates. Davis, K.P., L.A. McDermott, D.R. Snydman, and B.B. Aldridge. Microbiology Spectrum, 2024. 12(8): e0097624. PMID[38916355]. PMCID[PMC11302340].
[PubMed]. TB_08_2024.

3. Antibacterial Action of Penicillin Against Mycobacterium avium Complex. Deshpande, D., G. Magombedze, S. Srivastava, and T. Gumbo. IJTLD Open, 2024. 1(8): p. 362-368. PMID[39131587]. PMCID[PMC11308404].
[PubMed]. TB_08_2024.

4. Enhance the Antimycobacterial Activity of Streptomycin with Ebselen as an Antibiotic Adjuvant through Disrupting Redox Homeostasis. Dong, C., Y. Wang, Y. Cai, Y. Wu, W. Chen, L. Wang, X. Liu, L. Zou, and J. Wang. Drug Design, Development and Therapy, 2024. 18: p. 3811-3824. PMID[39219694]. PMCID[PMC11365518].
[PubMed]. TB_08_2024.

5. Tailoring Bisindolyl Methane Derivatives for Dual Applications: Substituent-directed Probing of Cyanide Ions and Anti-tubercular Activity. Fernandes, R.S., J. Kumari, A. Gangopadhyay, D. Sriram, and N. Dey. Journal of Molecular Liquids, 2024. 410: 125266. ISI[001287683100001].
[WOS]. TB_08_2024.

6. Bioinformatic Approaches Identify Hybrid Antibiotics against Tuberculosis Via D-amino Acid-activating Adenylation Domains from Cordyceps militaris. Gao, Y., L. Liao, Y. Xu, J. Huang, J. Gao, and L. Li. Journal of Natural Products, 2024. 87(8): p. 2110-2119. PMID[39052090].
[PubMed]. TB_08_2024.

7. Rapid Discovery of Antimicrobial and Antimalarial Agents from Natural Product Fragments. Han, J.Y., X.T. Liu, L.X. Zhang, W.C. Van Voorhis, R.J. Quinn, and M.M. Liu. Separations, 2024. 11(7): 194. ISI[001277725800001].
[WOS]. TB_08_2024.

8. Pyrimidine-based Sulfonamides and Acetamides as Potent Antimicrobial Agents: Synthesis, Computational Studies, and Biological Assessment. Indalkar, S., D. Kumar Sahoo, D.S. Bhange, M. Waghmode, S. Shekh, L.D. Gaikwad, and K.M. Gadave. Bioorganic Chemistry, 2024. 151: 107667. PMID[39067418].
[PubMed]. TB_08_2024.

9. Intrinsic Clarithromycin Heteroresistance in Mycobacterium avium. Ito, A., Y. Nanjo, C. Kajiwara, A. Shiozawa, N. Urabe, S. Homma, K. Kishi, K. Yamada, Y. Ishii, and K. Tateda. Journal of Infection and Chemotherapy, 2024. 30(8): p. 752-756. PMID[38369123].
[PubMed]. TB_08_2024.

10. Identification of Antimycobacterial 8-hydroxyquinoline Derivatives as In Vitro Enzymatic Inhibitors of Mycobacterium tuberculosis Enoyl-acyl Carrier Protein Reductase. Joaquim, A.R., M.S. Lopes, I.S. Fortes, C. de Bem Gentz, A. de Matos Czeczot, M.A. Perelló, C.D. Roth, M.H. Vainstein, L.A. Basso, C.V. Bizarro, P. Machado, and S.F. de Andrade. Bioorganic Chemistry, 2024. 151: 107705. PMID[39137600].
[PubMed]. TB_08_2024.

11. Antitubercular Evaluation of Dihydropyridine-triazole Conjugates: Design, Synthesis, In Vitro Screening, Sar and In Silico ADME Predictions. Kushawaha, A.K., A.K. Jaiswal, J. Gupta, S. Katiyar, A. Ansari, H. Bhatt, S.K. Sharma, A.D. Choudhury, R.S. Bhatta, B.N. Singh, and K.V. Sashidhara. RSC Medicinal Chemistry, 2024. 15(8): p. 2867-2881. PMID[39149103]. PMCID[PMC11324066].
[PubMed]. TB_08_2024.

12. Zafirlukast Induces DNA Condensation and Has Bactericidal Effect on Replicating Mycobacterium abscessus. Niet, S., K.D. Green, I.M. Schimmel, J. Bakker, B. Lodder, E.A. Reits, S. Garneau-Tsodikova, and N.N. van der Wel. Antimicrobial Agents and Chemotherapy, 2024. 68(8): e0002924. PMID[38990015]. PMCID[PMC11304721].
[PubMed]. TB_08_2024.

13. Exploring Indonesian Actinomycete Extracts for Anti-tubercular Compounds: Integrating Inhibition Assessment, Genomic Analysis, and Prediction of its Target by Molecular Docking. Nurkanto, A., Masrukhin, J.C. Erdian Tampubolon, M.F. Ewaldo, A.L. Putri, S. Ratnakomala, R. Setiawan, A. Fathoni, K.D. Palupi, Y. Rahmawati, D. Waluyo, E.E. Prabandari, S. Pujiyanto, Y. Sumii, A. Agusta, N. Shibata, S. Matsumoto, and T. Nozaki. Heliyon, 2024. 10(15): e35648. PMID[39170210]. PMCID[PMC11336835].
[PubMed]. TB_08_2024.

14. Antimicrobial Effect of Chitosan Nanoparticles and Allium Species on Mycobacterium Tuberculosis and Several Other Microorganisms. Olivas-Flores, J., J.R. Chávez-Méndez, N.A. Castillo-Martínez, H.J. Sánchez-Pérez, A. Serrano-Medina, and J.M. Cornejo-Bravo. Microorganisms, 2024. 12(8). PMID[39203447]. PMCID[PMC11356778].
[PubMed]. TB_08_2024.

15. Ligand-based Virtual Screening for Discovery of Indole Derivatives as Potent DNA Gyrase ATPase Inhibitors Active against Mycobacterium tuberculosis and Hit Validation by Biological Assays. Pakamwong, B., P. Thongdee, B. Kamsri, N. Phusi, S. Taveepanich, K. Chayajarus, P. Kamsri, A. Punkvang, S. Hannongbua, J. Sangswan, K. Suttisintong, S. Sureram, P. Kittakoop, P. Hongmanee, P. Santanirand, J. Leanpolchareanchai, J. Spencer, A.J. Mulholland, and P. Pungpo. J Journal of Chemical Information and Modeling, 2024. 64(15): p. 5991-6002. PMID[38993154]. PMCID[PMC11323271].
[PubMed]. TB_08_2024.

16. A Hit Expansion of 3-benzamidopyrazine-2-carboxamide: Toward Inhibitors of prolyl-tRNA Synthetase with Antimycobacterial Activity. Pallabothula, V.S.K., N.T. Abdalrahman, M. Mori, A.H. Fekri, O. Janďourek, K. Konečná, P. Paterová, M. Novák, P. Dudášová-Hatoková, P. Štěrbová-Kovaříková, C. Castellano, F. Meneghetti, S. Villa, J. Kuneš, M. Juhás, and J. Zitko. Arch Pharm, 2024. 357(8): e2400171. PMID[38710636].
[PubMed]. TB_08_2024.

17. Glycogen Synthase Kinase 3 Inhibition Controls Mycobacterium tuberculosis Infection. Peña-Díaz, S., J.D. Chao, C. Rens, H. Haghdadi, X. Zheng, K. Flanagan, M. Ko, T. Shapira, A. Richter, D. Maestre-Batlle, J.O. Canseco, M.G. Gutierrez, K.D. Duc, S. Pelech, and Y. Av-Gay. iScience, 2024. 27(8): 110555. PMID[39175770]. PMCID[PMC11340618].
[PubMed]. TB_08_2024.

18. N-acyl Phenothiazines as Mycobacterial ATP Synthase Inhibitors: Rational Design, Synthesis and In Vitro Evaluation against Drug Sensitive, RR and MDR-TB. Reddyrajula, R., S. Perveen, A. Negi, U. Etikyala, V. Manga, R. Sharma, and U.K. Dalimba. Bioorganic Chemistry, 2024. 151: 107702. PMID[39142196].
[PubMed]. TB_08_2024.

19. Identification of 2-(N-aryl-1,2,3-triazol-4-yl) Quinoline Derivatives as Antitubercular Agents Endowed with InhA Inhibitory Activity. Sabt, A., M.H. Abdulla, M.S. Ebaid, J. Pawełczyk, H.A. Abd El Salam, N.T. Son, N.X. Ha, M.A. Vaali Mohammed, T. Traiki, A.E. Elsawi, B. Dziadek, J. Dziadek, and W.M. Eldehna. Frontiers in Chemistry, 2024. 12: 1424017. PMID[39170867]. PMCID[PMC11337105].
[PubMed]. TB_08_2024.

20. In Vitro and Intracellular Activity of Vaborbactam Combined with Β-lactams against Mycobacterium abscessus. Sanchez, L., M. Bitar, Q. Herail, D. Dorchêne, J.E. Hugonnet, M. Arthur, and J.L. Mainardi. Journal of Antimicrobial Chemotherapy, 2024. 79(8): p. 1914-1918. PMID[38943535].
[PubMed]. TB_08_2024.

21. Development of Narrow-spectrum Topoisomerase-targeting Antibacterials against Mycobacteria. Sterle, M., E. Habjan, M. Piga, P. Peršolja, M. Durcik, J. Dernovšek, P. Szili, M.S. Czikkely, N. Zidar, I. Janez, C. Pal, T. Accetto, L.A. Pardo, D. Kikelj, L. Peterlin Mašič, T. Tomašič, W. Bitter, A.E. Cotman, A. Speer, and A. Zega. European Journal of Medicinal Chemistry, 2024. 276: 116693. PMID[39053193].
[PubMed]. TB_08_2024.

22. Identification of Axinellamines A and B as Anti-tubercular Agents. Strong, E.J., L. Tan, S. Hayes, H. Whyte, R.A. Davis, and N.P. West. Marine Drugs, 2024. 22(7). PMID[39057407]. PMCID[PMC11277618].
[PubMed]. TB_08_2024.

23. Design of a New Class of Broad-spectrum Therapeutics Targeted to Drug-resistant Bacteria. Surendran, A., A. Turnbull, A. Flockhart, F. Findlay-Greene, M. Nowosielska, D. Morrison, D.J. Mincher, and S. Donnellan. All Life, 2024. 17(1): 2379309. ISI[001274128600001].
[WOS]. TB_08_2024.

24. Assessment of the Efficacy of the Antihistamine Drug Rupatadine Used Alone or In Combination against Mycobacteria. Tian, X., W. Ma, B. Yusuf, B. Su, J. Hu, and T. Zhang. Pharmaceutics, 2024. 16(8). PMID[39204394]. PMCID[PMC11359651].
[PubMed]. TB_08_2024.

25. Antimycobacterial Activity of Plant Compounds against Extensively Drug Resistant (XDR-TB) Mycobacterium tuberculosis. Veeramuthu, D., I. Savarimuthu, I.A. Khan, H.A. Alodaini, A.A. Hatamleh, and S. Antony. Journal of King Saud University Science, 2024. 36(9): 103351. ISI[001283282800001].
[WOS]. TB_08_2024.

Patent Citations

26. Preparation of Rifabutin analogs for the treatment of bacterial diseases. Antraygues, K., M. Bourotte, G. E. Dale, O. Defert, A. Dreneau, M. Gitzinger, S. Lociuro, M. Maingot, A. Michelotti, V. Trebosc, N. Willand, N. Khan, L. Hofmann, and M. Miljkovic. Patent. 2024. WO2024-EP529752024165591: 159pp.
[Patent]. TB_08_2024.